Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Stephen Ju from UBS issued a price target of $3.40 for TRVG on 2026-04-27 13:38:52.The adjusted price target was set to $3.40.At the time of the announcement, TRVG...
April 27, 2026 TRVG -0.47%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| FEDU Four Seasons Education (C | 10.47
9.29% | ||||||||||||||||||
| AHG Akso Health Group | 2.21
8.60% | ||||||||||||||||||
| SQNS Sequans Communications S. | 3.52
6.67% | ||||||||||||||||||
| AMBO Ambow Education Holding L | 2.34
5.41% | ||||||||||||||||||
| ATHE Alterity Therapeutics Lim | 4.65
5.40% | ||||||||||||||||||
| CLGN CollPlant Biotechnologies | 0.44
5.26% | ||||||||||||||||||
| DXF Eason Technology Limited | 0.54
5.10% | ||||||||||||||||||
| IONR ioneer Ltd | 4.05
4.92% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 0.84%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 1.78%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK -1.53%